Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dexamethasone + local anaesthetic is a combination intra-articular injection used for the management of pain and inflammation in joint disorders, specifically temporomandibular joint (TMJ) internal derangement. Dexamethasone is a potent synthetic glucocorticoid that acts as an agonist of the glucocorticoid receptor, providing long-acting anti-inflammatory and immunosuppressive effects by inhibiting pro-inflammatory cytokine production and stabilizing lysosomal membranes. The local anaesthetic component (such as lidocaine or bupivacaine) provides immediate, short-term analgesia by blocking voltage-gated sodium channels, thereby inhibiting nerve impulse conduction. In clinical trials conducted by the University of Anbar, this combination served as a standard-of-care comparator to evaluate the efficacy of platelet-rich plasma (PRP) in improving mouth opening and reducing joint clicking and pain associated with TMJ internal derangement.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on dexamethasone + local anaesthetic.